Delivery Order SPE2DB20D2104-SPE2DB25FMPBM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Norethindrone-Ethinyl Estradiol 0.5-2.5mg tablets (28-count package), with a contract ceiling value of $1,232.93. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for completion by September 17, 2025, with performance to occur at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,192.88 to AmerisourceBergen Drug Corp for the supply of Estradiol 10 mcg vaginal inserts (8-count packages) under a firm fixed-price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,204.78 firm-fixed-price delivery order covers the supply of 4564074255 ESTRADIOL-NORETH 0.5-0.1 MG TB UU 28S, with a period of performance through March 26, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $2,628.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Estradiol 10 MCG Vaginal Insert (8 count) on August 7, 2025, with completion scheduled for August 8, 2025. This delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $2,563.89. The contract is to provide Estradiol 10 mcg vaginal inserts with a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order as well as an indefinite delivery contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,217.22 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg in a 28-tablet package. This non-set-aside, firm fixed price delivery order was competitively awarded and is scheduled for completion by August 28, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.08 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,565.34 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Estradiol 10 MCG Vaginal Insert (18-count). This competitively awarded, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. No set-aside designation was applied to this contract action. This delivery order represents a child action under...
- The Defense Logistics Agency awarded a $1,161.18 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count). This firm fixed price contract, with an ultimate completion date of August 7, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price Delivery Order valued at $1,280.73 to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The order is for the delivery of Estrogen-Methyltestos F.S. Tablets, 100-count, to be performed in Conshohocken, Pennsylvania by March 1, 2024. This Delivery Order is placed under an Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp as a single-award contract, with a potential value of up...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMPBMDelivery Order
The Defense Logistics Agency (DLA) awarded a $1,404.76 delivery order to AmerisourceBergen Drug Corp for the supply of Estradiol-Norethindrone 0.5-0.1 mg tablets (28-count units), with an ultimate completion date of April 23, 2025. This is a firm fixed-price, non-set-aside contract executed on April 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting relationship with the DLA. This award is a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a wide range of medications, vaccines, and medical supplies to support military and federal healthcare systems globally. As a major pharmaceutical distributor and the only awardee on this substantial medical supply contract vehicle, AmerisourceBergen demonstrates substantial capability in meeting federal procurement requirements for critical pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/22/25 |